Pilot Clinical Trial to Explore Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients
Status:
Completed
Trial end date:
2022-11-20
Target enrollment:
Participant gender:
Summary
This study is a multi-center, single-arm, open-label, pilot clinical trial to explore
efficacy and safety of Pyramax in mild to moderate COVID-19 patients